rs193920967
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001377265.1(MAPT):c.69G>C(p.Arg23Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
 Genomes: not found (cov: 32) 
Consequence
 MAPT
NM_001377265.1 missense
NM_001377265.1 missense
Scores
 4
 15
Clinical Significance
Conservation
 PhyloP100:  2.35  
Publications
1 publications found 
Genes affected
 MAPT  (HGNC:6893):  (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008] 
MAPT Gene-Disease associations (from GenCC):
- Pick diseaseInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- semantic dementiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- supranuclear palsy, progressive, 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- progressive supranuclear palsy-parkinsonism syndromeInheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (MetaRNN=0.19190198). 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MAPT | NM_001377265.1 | c.69G>C | p.Arg23Ser | missense_variant | Exon 2 of 13 | ENST00000262410.10 | NP_001364194.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| MAPT | ENST00000262410.10 | c.69G>C | p.Arg23Ser | missense_variant | Exon 2 of 13 | 1 | NM_001377265.1 | ENSP00000262410.6 | 
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Uncertain significance 
Submissions summary: Uncertain:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Prostate cancer    Uncertain:1 
-
Science for Life laboratory, Karolinska Institutet
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;.;.;.;.;.;.;.;.;T;.;. 
 Eigen 
 Benign 
 Eigen_PC 
 Benign 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D;D;D;D;D;.;.;.;.;. 
 M_CAP 
 Benign 
D 
 MetaRNN 
 Benign 
T;T;T;T;T;T;T;T;T;T;T;T 
 MetaSVM 
 Benign 
T 
 MutationAssessor 
 Benign 
L;L;L;L;L;L;L;L;L;L;L;L 
 PhyloP100 
 PrimateAI 
 Benign 
T 
 PROVEAN 
 Benign 
N;N;N;N;N;N;N;N;N;.;.;. 
 REVEL 
 Benign 
 Sift 
 Uncertain 
D;D;D;D;D;D;D;D;D;.;.;. 
 Sift4G 
 Benign 
T;T;T;T;T;T;T;T;T;T;T;T 
 Polyphen 
D;P;D;.;P;P;P;P;D;D;P;. 
 Vest4 
 MutPred 
Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);Loss of ubiquitination at K24 (P = 0.0598);
 MVP 
 MPC 
 0.68 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.